ESC 2018: Oral Anticoagulants + Antiplatelets Linked to Poor Outcome in Atrial Fibrillation
Combined oral anticoagulant and antiplatelet therapy was harmful to patients without an indication for antiplatelets.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.